Volume 5, Issue 2 supplement | European Radiology

Search all European Radiology articles

Volume 5, Issue 2 supplement

April 1995

Filter by

Volume:

Sort by

Date published:

New to old Old to new

23 articles in this issue

Introduction to new areas of use for iotrolan
P. Aspelin
OriginalPaper Pages: S1 - S2
From iodide to iotrolan: history and argument
M. Sovak
OriginalPaper Pages: S3 - S7
Preclinical findings with iotrolan: a short review
U. Speck
OriginalPaper Pages: S8 - S13
Myelography: current status and post-marketing experience with iotrolan
K. Ringel
OriginalPaper Pages: S14 - S17
Arthrography of the glenohumeral joint: experience with a non-ionic dimeric contrast agent and future perspectives
L. Kopka
M. Funke
E. Grabbe
OriginalPaper Pages: S18 - S23
A Japanese phase III multicenter comparison of iotrolan 280 with iopamidol 300 in peripheral arteriography
S. Hori
OriginalPaper Pages: S24 - S29
Peripheral and penile angiography with iotrolan 280 versus non-ionic monomers: results of the European clinical phase II and III trials
J. K. Gmeinwieser
B. -I. Wenzel-Hora
OriginalPaper Pages: S30 - S38
Iotrolan in cerebral angiography: a Japanese phase III multicenter comparative study with iopamidol
H. Sumie
H. Katayama
OriginalPaper Pages: S39 - S44
Iotrolan, a non-ionic dimeric contrast agent in cerebral angiography
S. Bien
OriginalPaper Pages: S45 - S48
A Japanese multicenter comparison of iotrolan 280 with iopamidol 300 in head CT
K. Sakurai
OriginalPaper Pages: S49 - S53
Iotrolan in head and body CT — European experience
O. Schubiger
M. Friedrich
W. Rodl
OriginalPaper Pages: S54 - S57
A Japanese multicenter comparison of iotrolan 280 with iopamidol 300 in intravenous urography
Y. Narimatsu
K. Hiramatsu
OriginalPaper Pages: S58 - S62
Iotrolan in urography: efficacy and tolerance in comparison with iohexol and iopamidol
J. M. G. Adolph
H. Engelkamp
B. I. Wenzel-Hora
OriginalPaper Pages: S63 - S68
Iotrolan in pediatric examinations
J. Tröger
B. I. Wenzel-Hora
K. Darge
OriginalPaper Pages: S69 - S73
The effect of contrast agents on renal function
S. Dorph
OriginalPaper Pages: S74 - S78
Renal tolerance of iotrolan 280 —a meta-analysis of 14 double-blind studies
W. Clauß
J. Dinger
C. Meißner
OriginalPaper Pages: S79 - S84
Clinical safety assessment of iotrolan 280 in European clinical studies
O. M. Silvay-Mandeau
C. Meissner
B. I. Wenzel-Hora
OriginalPaper Pages: S85 - S88
Clinical safety of iotrolan 280: the Japanese experience
C. Brünger
OriginalPaper Pages: S89 - S92
Intravascular iotrolan in the US: work in progress
H. A. Goldstein
G. Jacob
OriginalPaper Pages: S93 - S95
Future directions in computerized tomography
W. E. Torres
OriginalPaper Pages: S96 - S98
Future directions in vascular interventional radiology
M. A. Bettmann
OriginalPaper Pages: S99 - S102
The non-ionic dimers — some theoretical and clinical considerations
P. Dawson
OriginalPaper Pages: S103 - S106
Looking into the future: iotrolan and beyond
H. P. Niendorf
T. Fritzsch
R. Schürmann
OriginalPaper Pages: S107 - S111